Psychiatry Res. 1985 Sep;16(1):21-6.

Treatment of attention deficit disorder with DL-phenylalanine.

Abstract

Nineteen patients meeting the criteria for attention deficit disorder, residual type (adult hyperactivity), were given a 2-week double-blind crossover of DL-phenylalanine versus placebo. Thirteen subjects completed the study; the mean global rating of improvement approached significance as compared with placebo. A significant improvement was noted on mood and mood lability. The phenylalanine responders were then continued on open drug, but lost all positive benefits within 3 months. A later open trial of L-phenylalanine produced no clinical effect.

PMID:: 3903813; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Phenylalanine

Grant Support

5R01MH-31130/MH/NIMH NIH HHS/United States

LinkOut - more resources

Supplemental Content

Save items

Related citations in PubMed

A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder. [J Child Adolesc Psychopharmaco...]
A double-blind, placebo-controlled withdrawal trial of dexmethylphenidate hydrochloride in children with attention deficit hyperactivity disorder.
Arnold LE, Lindsay RL, Conners CK, Wigal SB, Levine AJ, Johnson DE, West SA, Sangal RB, Bohan TP, Zeldis JB. J Child Adolesc Psychopharmacol. 2004 Winter; 14(4):542-54.
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type. [Am J Psychiatry. 1987]
An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type.
Reimherr FW, Wender PH, Wood DR, Ward M. Am J Psychiatry. 1987 Aug; 144(8):1071-3.
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. [Clin Ther. 2006]
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther. 2006 Feb; 28(2):266-79.
Review [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]. [Encephale. 2005]
Review [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].
Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP. Encephale. 2005 May-Jun; 31(3):337-48.
Review Pharmacotherapy of attention-deficit/hyperactivity disorder in adults. [J Clin Psychiatry. 1998]
Review Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wender PH. J Clin Psychiatry. 1998; 59 Suppl 7:76-9.

See reviews... See all...

Cited by 2 PubMed Central articles

Review An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. [Expert Rev Neurother. 2011]
Review An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wilens TE, Morrison NR, Prince J. Expert Rev Neurother. 2011 Oct; 11(10):1443-65.
Review Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths. [Theor Biol Med Model. 2005]
Review Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths.
Comings DE, Chen TJ, Blum K, Mengucci JF, Blum SH, Meshkin B. Theor Biol Med Model. 2005 Dec 23; 2:50. Epub 2005 Dec 23.

Recent activity

Clear Turn Off Turn On

Treatment of attention deficit disorder with DL-phenylalanine.
Treatment of attention deficit disorder with DL-phenylalanine.
Psychiatry Res. 1985 Sep ;16(1):21-6.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Treatment of attention deficit disorder with DL-phenylalanine.

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information